HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisanori Ariga Selected Research

Toll-Like Receptor 9

8/2006CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
1/2005Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hisanori Ariga Research Topics

Disease

15Neoplasms (Cancer)
07/2020 - 03/2003
8Esophageal Neoplasms (Esophageal Cancer)
10/2015 - 08/2006
4Neoplasm Metastasis (Metastasis)
12/2020 - 07/2004
4Prostatic Neoplasms (Prostate Cancer)
05/2013 - 05/2009
4Carcinoma (Carcinomatosis)
08/2006 - 07/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2021 - 10/2009
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2020 - 08/2018
2Hemorrhage
05/2013 - 01/2012
2Rectal Neoplasms (Rectal Cancer)
04/2013 - 04/2010
2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2011 - 04/2003
2Fibrosarcoma
08/2006 - 01/2005
2Adenocarcinoma
08/2006 - 08/2006
1Hematuria
08/2018
1Enterocolitis
04/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2012
1Lymphatic Metastasis
05/2012
1Cholangiocarcinoma
11/2011
1Disease Progression
04/2010
1Germinoma
12/2009
1Esophageal Squamous Cell Carcinoma
10/2009
1Vascular Diseases (Vascular Disease)
05/2009
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2005
1Necrosis
08/2004
1Residual Neoplasm
06/2003
1Astrocytoma (Pilocytic Astrocytoma)
06/2003

Drug/Important Bio-Agent (IBA)

4Docetaxel (Taxotere)FDA Link
07/2021 - 08/2006
3OligodeoxyribonucleotidesIBA
08/2006 - 08/2004
3A-factor (Streptomyces)IBA
01/2005 - 07/2004
2Cisplatin (Platino)FDA LinkGeneric
07/2021 - 10/2018
2Fluorouracil (Carac)FDA LinkGeneric
07/2021 - 10/2018
2AnticoagulantsIBA
08/2018 - 05/2009
2Toll-Like Receptor 9IBA
08/2006 - 01/2005
2Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2006 - 07/2004
2alvocidib (flavopiridol)IBA
08/2006 - 07/2004
1Ethiodized Oil (Ethiodol)FDA Link
08/2018
1iodofiltic acidIBA
09/2013
1SuspensionsIBA
04/2013
1Aurora Kinase AIBA
11/2011
1Prostate-Specific Antigen (Semenogelase)IBA
11/2011
1GemcitabineFDA Link
11/2011
1Iodine-125IBA
01/2011
1AndrogensIBA
05/2009
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2007
1CpG ODN 1826IBA
08/2006
1CytosineIBA
08/2006
1taxaneIBA
08/2006
1ThymidineIBA
08/2006
1GuanineIBA
08/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2005
1EnzymesIBA
10/2005
1Celecoxib (Celebrex)FDA Link
10/2005
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2005
1CytokinesIBA
01/2005
1CPG-oligonucleotideIBA
08/2004

Therapy/Procedure

21Radiotherapy
07/2020 - 03/2003
7Chemoradiotherapy
07/2021 - 08/2006
5Drug Therapy (Chemotherapy)
08/2018 - 06/2003
4Therapeutics
07/2020 - 08/2006
3Brachytherapy
05/2013 - 01/2011
2Esophagectomy
05/2012 - 10/2009
2Salvage Therapy
12/2009 - 10/2009
1Segmental Mastectomy (Lumpectomy)
12/2020
1Image-Guided Radiotherapy
08/2018
1Laparotomy
07/2012
1Lymph Node Excision (Lymph Node Dissection)
05/2012
1Prostatectomy (Retropubic Prostatectomy)
11/2011
1Neoadjuvant Therapy
11/2011
1Aftercare (After-Treatment)
10/2009
1Conformal Radiotherapy
05/2009
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2009
1Particle Accelerators
03/2003
1Transportation of Patients
03/2003